139 related articles for article (PubMed ID: 37350560)
1. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560
[TBL] [Abstract][Full Text] [Related]
2. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
3. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
4. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
[TBL] [Abstract][Full Text] [Related]
6. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Polterauer S; Reich O; Widschwendter A; Hadjari L; Bogner G; Reinthaller A; Joura E; Trutnovsky G; Ciresa-Koenig A; Ganhoer-Schimboeck J; Boehm I; Berger R; Langthaler E; Aberle SW; Heinze G; Gleiss A; Grimm C
Gynecol Oncol; 2022 Apr; 165(1):23-29. PubMed ID: 35177279
[TBL] [Abstract][Full Text] [Related]
8. Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
Hendriks N; Koeneman MM; van de Sande AJM; Penders CGJ; Piek JMJ; Kooreman LFS; van Kuijk SMJ; Hoosemans L; Sep SJS; de Vos Van Steenwijk PJ; van Beekhuizen HJ; Slangen BFM; Nijman HW; Kruitwagen RFPM; Kruse AJ
J Immunother; 2022 Apr; 45(3):180-186. PubMed ID: 35180719
[TBL] [Abstract][Full Text] [Related]
9. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Chen FP
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):475-8. PubMed ID: 24411029
[TBL] [Abstract][Full Text] [Related]
12. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study.
Fernández-Montolí ME; Tous S; Medina G; Castellarnau M; García-Tejedor A; de Sanjosé S
BJOG; 2020 Feb; 127(3):377-387. PubMed ID: 31631477
[TBL] [Abstract][Full Text] [Related]
13. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
15. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
16. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
[TBL] [Abstract][Full Text] [Related]
18. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?
Palmer JE; Ravenscroft S; Ellis K; Crossley J; Dudding N; Smith JH; Tidy JA
Cytopathology; 2016 Jun; 27(3):210-7. PubMed ID: 26415635
[TBL] [Abstract][Full Text] [Related]
19. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
Geisler S; Speiser S; Speiser L; Heinze G; Rosenthal A; Speiser P
Obstet Gynecol; 2016 Feb; 127(2):353-9. PubMed ID: 26942365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
